GC/gejc
Clinical trials for GC/gejc explained in plain language.
Never miss a new study
Get alerted when new GC/gejc trials appear
Sign up with your email to follow new studies for GC/gejc, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Donor cells join fight against advanced cancers
Disease control Not yet recruitingThis early study tests whether adding donor natural killer (NK) cells to standard maintenance therapy can safely help control advanced lung and colorectal cancers. About 20 adults will receive NK cell infusions alongside their usual drugs. The main goal is to check for side effec…
Matched conditions: GC/GEJC
Phase 1/2 • Sponsor: BOE Technology Group Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Two-Drug cocktail aims to shrink Hard-to-Treat esophageal and stomach tumors
Disease control Not yet recruitingThis phase II trial tests a combination of two drugs—sacituzumab tirumotecan (a targeted chemotherapy) and tagitanlimab (an immunotherapy)—as a second-line treatment for people with advanced esophageal squamous cell carcinoma or gastric/gastroesophageal junction adenocarcinoma. T…
Matched conditions: GC/GEJC
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New drug cocktail aims to tackle Hard-to-Treat stomach cancer
Disease control Not yet recruitingThis study tests a new biologic drug called HCB101 in combination with other cancer drugs (zolbetuximab and chemotherapy) for people with advanced gastric or gastro-esophageal cancer. The goal is to find a safe dose and see if the combination can shrink tumors. About 40 adults wi…
Matched conditions: GC/GEJC
Phase 1/2 • Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC